Virax Biolabs Group Limited (VRAX)
NASDAQ: VRAX · Real-Time Price · USD
0.200
-0.015 (-6.76%)
At close: Mar 9, 2026, 4:00 PM EDT
0.200
0.00 (0.00%)
After-hours: Mar 9, 2026, 4:00 PM EDT
Virax Biolabs Group Market Cap
Virax Biolabs Group has a market cap or net worth of $1.49 million as of March 9, 2026. Its market cap has decreased by -81.14% in one year.
Market Cap
1.49M
Enterprise Value
-1.31M
1-Year Change
-81.14%
Ranking
Category
Stock Price
$0.20
Market Cap Chart
Since the IPO on July 21, 2022, Virax Biolabs Group's market cap has decreased from $207.01M to $1.49M, a decrease of -99.28%. That is a compound annual growth rate of -74.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 1.59M | -37.97% |
| Dec 31, 2025 | 2.57M | -73.72% |
| Dec 31, 2024 | 9.77M | 269.37% |
| Dec 29, 2023 | 2.64M | -71.76% |
| Dec 30, 2022 | 9.36M | -95.48% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Calidi Biotherapeutics | 2.64M |
| 60 Degrees Pharmaceuticals | 2.64M |
| Artelo Biosciences | 2.42M |
| PMGC Holdings | 2.40M |
| Bone Biologics | 2.30M |
| Lyra Therapeutics | 2.27M |
| Clearmind Medicine | 2.05M |
| Adial Pharmaceuticals | 2.03M |